Report Detail

Pharma & Healthcare Global Ophthalmic Drugs Market Insights, Forecast to 2025

  • RnM2320849
  • |
  • 17 August, 2018
  • |
  • Global
  • |
  • 92 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Table of Contents

    1 Study Coverage

    • 1.1 Ophthalmic Drugs Product
    • 1.2 Key Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Ophthalmic Drugs Market Size Growth Rate by Type
      • 1.4.2 Dry Eye
      • 1.4.3 Glaucoma
      • 1.4.4 Infection/Inflammation
      • 1.4.5 Retinal Disorders
      • 1.4.6 Allergy
      • 1.4.7 Uveitis
      • 1.4.8 Others
    • 1.5 Market by Application
      • 1.5.1 Global Ophthalmic Drugs Market Size Growth Rate by Application
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Online Pharmacies
      • 1.5.4 Independent Pharmacies & Drug Stores
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Ophthalmic Drugs Market Size
      • 2.1.1 Global Ophthalmic Drugs Revenue 2016-2025
      • 2.1.2 Global Ophthalmic Drugs Sales 2016-2025
    • 2.2 Ophthalmic Drugs Growth Rate by Regions
      • 2.2.1 Global Ophthalmic Drugs Sales by Regions
      • 2.2.2 Global Ophthalmic Drugs Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Ophthalmic Drugs Sales by Manufacturers
      • 3.1.1 Ophthalmic Drugs Sales by Manufacturers
      • 3.1.2 Ophthalmic Drugs Sales Market Share by Manufacturers
      • 3.1.3 Global Ophthalmic Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Ophthalmic Drugs Revenue by Manufacturers
      • 3.2.1 Ophthalmic Drugs Revenue by Manufacturers (2016-2018)
      • 3.2.2 Ophthalmic Drugs Revenue Share by Manufacturers (2016-2018)
    • 3.3 Ophthalmic Drugs Price by Manufacturers
    • 3.4 Ophthalmic Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Ophthalmic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Ophthalmic Drugs Product Category
      • 3.4.3 Date of International Manufacturers Enter into Ophthalmic Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type

    • 4.1 Global Ophthalmic Drugs Sales by Type
    • 4.2 Global Ophthalmic Drugs Revenue by Type
    • 4.3 Ophthalmic Drugs Price by Type

    5 Breakdown Data by Application

    • 5.1 Overview
    • 5.2 Global Ophthalmic Drugs Breakdown Data by Application

    6 North America

    • 6.1 North America Ophthalmic Drugs by Countries
      • 6.1.1 North America Ophthalmic Drugs Sales by Countries
      • 6.1.2 North America Ophthalmic Drugs Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Ophthalmic Drugs by Type
    • 6.3 North America Ophthalmic Drugs by Application
    • 6.4 North America Ophthalmic Drugs by Company

    7 Europe

    • 7.1 Europe Ophthalmic Drugs by Countries
      • 7.1.1 Europe Ophthalmic Drugs Sales by Countries
      • 7.1.2 Europe Ophthalmic Drugs Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Ophthalmic Drugs by Type
    • 7.3 Europe Ophthalmic Drugs by Application
    • 7.4 Europe Ophthalmic Drugs by Company

    8 Asia Pacific

    • 8.1 Asia Pacific Ophthalmic Drugs by Countries
      • 8.1.1 Asia Pacific Ophthalmic Drugs Sales by Countries
      • 8.1.2 Asia Pacific Ophthalmic Drugs Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Ophthalmic Drugs by Type
    • 8.3 Asia Pacific Ophthalmic Drugs by Application
    • 8.4 Asia Pacific Ophthalmic Drugs by Company

    9 Central & South America

    • 9.1 Central & South America Ophthalmic Drugs by Countries
      • 9.1.1 Central & South America Ophthalmic Drugs Sales by Countries
      • 9.1.2 Central & South America Ophthalmic Drugs Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Ophthalmic Drugs by Type
    • 9.3 Central & South America Ophthalmic Drugs by Application
    • 9.4 Central & South America Ophthalmic Drugs by Company

    10 Middle East and Africa

    • 10.1 Middle East and Africa Ophthalmic Drugs by Countries
      • 10.1.1 Middle East and Africa Ophthalmic Drugs Sales by Countries
      • 10.1.2 Middle East and Africa Ophthalmic Drugs Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Ophthalmic Drugs by Type
    • 10.3 Middle East and Africa Ophthalmic Drugs by Application
    • 10.4 Middle East and Africa Ophthalmic Drugs by Company

    11 Company Profiles

    • 11.1 Aerie Pharmaceuticals
      • 11.1.1 Aerie Pharmaceuticals Company Details
      • 11.1.2 Company Description
      • 11.1.3 Sales, Revenue and Gross Margin of Ophthalmic Drugs
      • 11.1.4 Ophthalmic Drugs Product Description
      • 11.1.5 Recent Development
    • 11.2 ALLERGAN
      • 11.2.1 ALLERGAN Company Details
      • 11.2.2 Company Description
      • 11.2.3 Sales, Revenue and Gross Margin of Ophthalmic Drugs
      • 11.2.4 Ophthalmic Drugs Product Description
      • 11.2.5 Recent Development
    • 11.3 Valeant Pharmaceuticals International
      • 11.3.1 Valeant Pharmaceuticals International Company Details
      • 11.3.2 Company Description
      • 11.3.3 Sales, Revenue and Gross Margin of Ophthalmic Drugs
      • 11.3.4 Ophthalmic Drugs Product Description
      • 11.3.5 Recent Development
    • 11.4 Bayer AG
      • 11.4.1 Bayer AG Company Details
      • 11.4.2 Company Description
      • 11.4.3 Sales, Revenue and Gross Margin of Ophthalmic Drugs
      • 11.4.4 Ophthalmic Drugs Product Description
      • 11.4.5 Recent Development
    • 11.5 Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
      • 11.5.1 Genentech, Inc. (F. Hoffmann-La Roche Ltd.) Company Details
      • 11.5.2 Company Description
      • 11.5.3 Sales, Revenue and Gross Margin of Ophthalmic Drugs
      • 11.5.4 Ophthalmic Drugs Product Description
      • 11.5.5 Recent Development
    • 11.6 Novartis AG
      • 11.6.1 Novartis AG Company Details
      • 11.6.2 Company Description
      • 11.6.3 Sales, Revenue and Gross Margin of Ophthalmic Drugs
      • 11.6.4 Ophthalmic Drugs Product Description
      • 11.6.5 Recent Development
    • 11.7 Pfizer
      • 11.7.1 Pfizer Company Details
      • 11.7.2 Company Description
      • 11.7.3 Sales, Revenue and Gross Margin of Ophthalmic Drugs
      • 11.7.4 Ophthalmic Drugs Product Description
      • 11.7.5 Recent Development
    • 11.8 Regeneron Pharmaceuticals
      • 11.8.1 Regeneron Pharmaceuticals Company Details
      • 11.8.2 Company Description
      • 11.8.3 Sales, Revenue and Gross Margin of Ophthalmic Drugs
      • 11.8.4 Ophthalmic Drugs Product Description
      • 11.8.5 Recent Development
    • 11.9 Santen Pharmaceutical
      • 11.9.1 Santen Pharmaceutical Company Details
      • 11.9.2 Company Description
      • 11.9.3 Sales, Revenue and Gross Margin of Ophthalmic Drugs
      • 11.9.4 Ophthalmic Drugs Product Description
      • 11.9.5 Recent Development
    • 11.10 Shire
      • 11.10.1 Shire Company Details
      • 11.10.2 Company Description
      • 11.10.3 Sales, Revenue and Gross Margin of Ophthalmic Drugs
      • 11.10.4 Ophthalmic Drugs Product Description
      • 11.10.5 Recent Development

    12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 12.1 Market Opportunities and Drivers
    • 12.2 Market Challenges
    • 12.3 Market Risks/Restraints
    • 12.4 Key World Economic Indicators

    13 Value Chain and Sales Channels Analysis

    • 13.1 Value Chain Analysis
      • 13.1.1 Typical Suppliers of Key Ophthalmic Drugs Raw Material
      • 13.1.2 Ophthalmic Drugs Customers
    • 13.2 Sales Channels Analysis
      • 13.2.1 Sales Channels Analysis
      • 13.2.2 Distributors

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Author Details

      This report studies the global market size of Ophthalmic Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ophthalmic Drugs in these regions.
      This research report categorizes the global Ophthalmic Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

      In 2017, the global Ophthalmic Drugs market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Ophthalmic Drugs market based on company, product type, application and key regions.

      The various contributors involved in the value chain of Ophthalmic Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Ophthalmic Drugs include
      Aerie Pharmaceuticals
      ALLERGAN
      Valeant Pharmaceuticals International
      Bayer AG
      Genentech, Inc. (F. Hoffmann-La Roche Ltd.)
      Novartis AG
      Pfizer
      Regeneron Pharmaceuticals
      Santen Pharmaceutical
      Shire

      Market Size Split by Type
      Dry Eye
      Glaucoma
      Infection/Inflammation
      Retinal Disorders
      Allergy
      Uveitis
      Others
      Market Size Split by Application
      Hospital Pharmacies
      Online Pharmacies
      Independent Pharmacies & Drug Stores

      Market size split by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Ophthalmic Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
      To understand the structure of Ophthalmic Drugs market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Ophthalmic Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Ophthalmic Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
      To project the value and volume of Ophthalmic Drugs submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      In this study, the years considered to estimate the market size of Ophthalmic Drugs are as follows:
      History Year: 2013-2017
      Base Year: 2017
      Estimated Year: 2018
      Forecast Year 2018 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ophthalmic Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Ophthalmic Drugs . Industry analysis & Market Report on Ophthalmic Drugs is a syndicated market report, published as Global Ophthalmic Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Ophthalmic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $7,800.00
      3,026.36
      6,052.71
      3,501.44
      7,002.89
      423,309.90
      846,619.80
      277,407.78
      554,815.56
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report